Apremilast for treatment of recurrent erythema multiforme

Abstract

Recurrent erythema multiforme with oralinvolvement is therapeutically challenging.Apremilast has been used with success in resolvingthe oral aphthae of Behçet disease, prompting theuse of the drug in patients with oral erosions fromerythema multiforme. Three patients with oralerythema multiforme were given apremilast at dosesof 30-60mg daily. Complete clearance of the lesionswere observed in all three patients, including thoserefractory to other standard therapies. Apremilast maypresent an effective option for recurrent erythemamultiforme for patients who have failed trials antiviraland immunosuppressive therapies.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

  • Only published works are available at libraries.

Similar books and articles

L'unité Multiforme De L'action Catholique.L. Suenens - 1958 - Nouvelle Revue Théologique 80 (1):3-21.
Cranial measurements in patients with depressive illness.Howard James & John Pollitt - 1973 - Journal of Biosocial Science 5 (3):363-366.
Threat perceptions and avoidance in recurrent dreams.A. Zadra & D. C. Donderi - 2000 - Behavioral and Brain Sciences 23 (6):1017-1018.

Analytics

Added to PP
2017-06-12

Downloads
13 (#978,482)

6 months
2 (#1,157,335)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references